ABSTRACT
Introduction

59
Biomarkers in epidemiological and clinical trials have to be indicators of exposure and 60 must have several characteristics, including being robust, sensitive to changes, specific 61 to the dietary source and biologically and physiologically understandable [1] . In the 62 food research field, this means that biomarkers have to be an objective measure of 63 intake and an evaluated indicator of food intervention [2] . There has been much in-64 depth discussion concerning their ability to solve classical problems regarding 65 estimating an index of quantitative exposure to individual food [1] [2] [3] , and recently, 66 identifying dietary patterns that may be related to major health benefits. Hence, there is 67 an increased interest in biomarker research for the development of new functional 68 foods, as well as for the validation of existing biomarkers [4] . Therefore, global 69 metabolic approaches need to be carried out in order to evaluate the role of individual or 70 groups of metabolites in the discrimination of selected food consumption.
71
After consumption of polyphenols, beneficial health effects in the prevention of diseases 72 have been widely analysed in in vivo and in vitro studies [5] [6] [7] . In particular, the 73 consumption of grape-derived products such as red wine (RW) and dealcoholized RW 74 (DRW) has been associated with a protective effect against cardiovascular diseases, 75 possibly through their anti-inflammatory and antihypertensive activities [5, 8] . These 76 associations were first linked to phytochemicals found in foods, which could exert their 77 biological activity. However, in recent years there has been increasing attention paid to 78 the metabolites formed in the organism, especially those formed by microbiota, due to 79 their role in the prevention of some diseases such as obesity and diabetes [9, 10] . This 80 supposes an increase in the variety of metabolites found in biofluids after consumption, 81 and therefore an increased number of possible food biomarkers [11] . Moreover, new 82 targeted and untargeted approaches have also increased the range of metabolites found 83 (2.5,50); (2.6,0); (3,0); (3.1,92); (3.5,92) . The MS/MS parameters used were as 145 previously described [16, 17] . 
Quantitative analysis
148
For quantification purposes, data were collected using the multiple reaction monitoring 149 (MRM) mode (Table 1 and Table 2 ) with a dwell time of 10 ms. When commercial 150 standards were not available, concentrations were quantified using the most similar 151 compound standard curve. Results were expressed as their equivalents [16] . The mean 152 recovery of analytes ranged from 87% to 109%, and accuracy and precision of analytes 153 at different concentrations were <15% [16, 17] . interventions and baseline or gin period, a binary stepwise logistic regression analysis 166 was performed to assess which metabolite combination predicted the wine intervention.
167
For this purpose, 80% of random samples of wine interventions and baseline or gin 168 periods were used as a training set, in which the logistic regression model was Table S3 . In 174 addition to the metabolites analysed in this study, resveratrol data from previous 175 analysis [15] were included to be evaluated and compared, since resveratrol has already 176 been described as a wine intake biomarker [12, 13] .
177
The optimal cut-off for the ROC curves was determined through the identification of the 178 shortest distance to the optimal point (0,1) for which specificity and sensitivity was 179 calculated.
180
To estimate the association between fasting plasma and 24-h urine in the prediction 181 models and within the phenolic metabolite groups, the Spearman correlation 182 coefficients were calculated. Statistical significance was defined as P ≤ 0.05.
183
Results
184
Urine and plasma analysis of targeted polyphenol metabolomic pattern
185
Nineteen individual metabolites and conjugates of (epi)catechin, methyl(epi)catechin 186 and dihydroxyphenyl-γ-valerolactone (DHPV), and 10 phenolic acids including 187 methylgallic sulfate and the group of total resveratrol metabolites significantly increased 188 in urine after RW or DRW interventions compared to the baseline or gin periods (Table   189 1). Only ethylgallate metabolites showed a statistically significant difference between Table 2 ).
193
The PCA differentiated easily between urinary samples from RW and DRW and the baseline or gin period were subjected to a stepwise variable selection method.
213
The results of the model for each type of sample are shown in Table 3 . Metabolites (Table 4 and Supporting Information Fig. S2 ). In hydrolyzed urine, the best 226 sensitivity, specificity and AUC were obtained for the model, followed by ethylgallate.
227
In non-hydrolyzed urine samples, the groups of ethylgallate, methylgallic and Table S1 ). The increment 261 observed after RW intake may be due to the fact that ethylgallate could also be formed have also used these kind of approaches to evaluate statistical differences between 267 groups in searching for polyphenol biomarkers [14, 17, 23] and sometimes they only 268 focused on a few metabolites that could not represent the global fingerprint [14] .
269
In this study, the metabolites that displayed significant differences between both wine 270 interventions and the baseline or gin period were selected as metabolite biomarker 271 candidates to be evaluated in the stepwise logistic regression analysis. This approach, 272 traditionally used in clinical diagnosis [24] , allows the identification of combinations of 273 metabolites from several origins that increased their discriminate power regarding single 274 metabolites. To our knowledge, this approach has been applied for the first time in 275 targeted studies of polyphenol food research. Advantages over previous works were the 276 high number of metabolites quantified that were added to this new step, which allowed 277 the discrimination of those metabolites as better predictors of wine intake.
278
All of the metabolites included in the model (Table 3) could come from the microbial 279 degradation of several wine phenolics [11] and some of them are also present in wine 280 composition, such as gallic acid, ethylgallate and 2,4-dihydroxybenzoic acid [16, 25, 281 26]. Gallic acid could also be released from several compounds present in wine, such as 282 gallates and anthocyanins [14, 27] . 2,4-Dihydroxybenzoic acid has also been described 283 as coming from the degradation of anthocyanins [28] and 3-hydroxyphenylacetic and p-284 coumaric acids, derived from procyanidins and anthocyanins, respectively [18, 29] , 285 which can be found in high content in wine [25] . Other analysed phenolic acids were 286 not considered in the model since they were less discriminant as most arise from several 287 food compounds. Thus, these metabolites could be misleading if they were considered 288 as biomarkers, as has previously been suggested after the intake of berries [11, 30] .
289
Once the model for each kind of sample was obtained, the AUC, sensitivity and 290 specificity and ROC curves evaluated their capacity to discriminate wine consumers. In proposed as good biomarkers of wine intake [12, 13] , but microbial-derived metabolites 296 have not been evaluated before. As was discussed above, one of the characteristics of a 297 good biomarker is being specific to food intake, thus resveratrol is well known for being 298 almost exclusively distributed in grape products [31] . The fact to validate biomarkers is 299 of great importance since there is the need for objective measures of food exposure that 300 allow accurate measures taking into account their bioavailability [32] . Other phenolic 301 groups with good but lower AUC values than the model were ethylgallate and gallic 302 acid metabolites (Table 4) . Thus, they could also be considered as biomarkers of wine 303 intake. Previously, some authors positively associated gallic acid and methylgallic acid 304 with the consumption of wine [33] , but, to our knowledge, no associations have been 305 published for ethylgallate. Gallic acid has even been described as the main metabolite of 306 ethylgallate, with longer Tmax and t 1/2 than its parent compound [34] . Both ethylgallate 307 and gallic acid have been described in other foods, such as grape products, wine and 308 vinegar, and tea, nuts and berries [25] . Other metabolites such as (epi)catechin and 309 valerolactones were less discriminant than those described metabolites and the model. The type of sample matrix in which biomarkers are measured also influences biomarker 318 evaluation [37] . Twenty-four hour urine has been described as the gold standard sample 319 for biomarker evaluation [38] and it provides a better measure of total polyphenol 320 metabolites than fasting plasma as it provides a better index of intake [1] . However, for 321 practical reasons, 24-h urine is not an easy sample to obtain in large-scale 322 epidemiological studies [1] . Consequently, we have assessed that fasting plasma should 323 be considered for biomarker determination. In this study, individual and phenolic 324 metabolite groups along with the score obtained from the prediction model (Supporting
325
Information Fig. S3 ) were correlated between fasting plasma and 24-h urine (Table 5) .
326
The best correlations were observed among model scores from hydrolyzed and non-327 hydrolyzed samples, indicating that those volunteers that were better classified as wine 328 consumers were done so through both urine and plasma samples (r=0.565 and r=0.599, 329 respectively P<0.001). Valerolactones and gallic acid microbial metabolites that also 330 had significant correlations were selected for their important role as biomarkers in urine, 331 and possible presence in fasting plasma due to their longer half-life [34, 36] .
332
Ethylgallate could not be evaluated due to the low concentrations obtained in plasma 333 since the Tmax and half-lives of ethylgallate were expected to be lower than its main 334 metabolite gallic acid [34] . Although the coefficients of correlation were significant, the 335 r values were clinically moderate (r < 0.750) [37] , which was similar to previous studies 336 that correlated urinary and plasma alkylresorcinol metabolites [37] . Correlations 337 between 24-h urine and fasting plasma have been previously described for total 338 flavonols in a crossover trial with a low flavonoid diet or with the same diet 339 supplemented with flavonols (r=0.624) [39] , as well as for isoflavones, using spot respectively, from the MINECO. We thank Torres SA for providing the red wine and 368 dealcoholized red wine used in the study, and Xoriguer Gin for providing the gin used 369 in the study.
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